Mariel Therapeutics, Inc.
Records under this name other than patents Mariel Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Mariel Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,696,410 | Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors Term ended Term ended Oct 26, 2020 · USPTO record | Term ended | Term ended Oct 26, 2020 | USPTO record |
| US 6,632,618 | Morphogenic protein-specific cell surface receptors and uses therefor Term ended Term ended Oct 14, 2020 · USPTO record | Term ended | Term ended Oct 14, 2020 | USPTO record |
| US 6,495,513 | Morphogen-enhanced survival and repair of neural cells Term ended Term ended Dec 17, 2019 · USPTO record | Term ended | Term ended Dec 17, 2019 | USPTO record |
| US 6,368,787 | Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements Term ended Term ended Dec 16, 2019 · USPTO record | Term ended | Term ended Dec 16, 2019 | USPTO record |
| US 6,677,432 | Mutations of the C-terminal portion of TGF-&bgr; superfamily proteins Term ended Term ended Aug 16, 2019 · USPTO record | Term ended | Term ended Aug 16, 2019 | USPTO record |
| US 6,399,569 | Morphogen treatments for limiting proliferation of epithelial cells Term ended Ended no later than Jun 4, 2019 · USPTO record | Term ended | Ended no later than Jun 4, 2019 | USPTO record |
| US 7,803,369 | Devices and method for repair of larynx, trachea, and other fibrocartilaginous tissues Lapsed on the fee record Ended Sep 28, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 28, 2018 | USPTO record |
| US 6,013,856 | Terminally sterilized osteogenic devices and preparation thereof Term ended Term ended Sep 23, 2018 · USPTO record | Term ended | Term ended Sep 23, 2018 | USPTO record |
| US 6,288,031 | Method for reducing extravasation of effector cells Term ended Term ended Sep 11, 2018 · USPTO record | Term ended | Term ended Sep 11, 2018 | USPTO record |
| US 8,802,626 | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects Term ended Term ended Jul 29, 2018 · USPTO record | Term ended | Term ended Jul 29, 2018 | USPTO record |